DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20172106

Study of the correlation between red blood cell parameters in the patients with coronary heart disease and heart failure

Mohamed Abdirahman Abdinur, Xie Yong, Kong Lingcai, Farah Abdidahir Mohamud, Jamac Abdidahir Mohamud, Sami Ullahi

Abstract


Background: An increase of red blood cell distribution width (RDW) may have a certain effect to predict and evaluate the incidence and prognosis of coronary heart disease or chronic heart failure.

Methods: Our retrospective study covered a total of 230 patients that were included due to a variety of indications for coronary angiography. Patients were defined into 2 categories; CAG (-) group (n=100), and CAG (+) group (n=130). The 2 groups were compared in order to investigate the differences between their RDW and other factors related and then further were sub-dived into 4 groups according to the NYHA functional class.

Results: We observed that the patients in CAG (-) group 12.78±0.90; CAG (+) group 12.90±1.10 and had no significant difference in RDW. However higher RDW in patients with HF on all-cause was detected, 13.50±1.12 of group CAG (-)/NYHA II-IV and 13.39±1.31 of group CAG (+)/NYHA II-IV and there is statistical difference compared to group CAG (-)/NYHAI and group CAG (+)/NYHA I which were 12.80±0.47 and 12.87±0.69 respectively (P<0.001). There has no difference between the HF groups CAG (-)/NYHA II-IV and CAG (+)/NYHA II-IV group with (P=0.920), and no difference between groups without heart failure of (P=0.979).

Conclusions: Although RDW had no predictive ability of coronary heart disease, but the elevation of RDW was highly and independently associated with chronic HF. Therefore, RDW can be clinically used as a parameter in risk stratification of patients with HF.


Keywords


Coronary Heart Disease, Heart failure, Red blood cell distribution width

Full Text:

PDF

References


Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975

Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22(3):228-36.

Bui AL, Horwich TB. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30-41.

Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nature Reviews Cardiology. 2016;13:368-78.

Liu L, Eisen HJ. Epidemiology of heart failure and scope of the problem. Cardiol Clin. 2014;32(1):1-8,

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics- 2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146-603.

Laszczynska O, Severo M, Friões F, Lourenço P, Silva S, Bettencourt P, et al. Validity of the Seattle Heart Failure Model for prognosis in a population at low coronary heart disease risk. J Cardiovasc Med. 2016;17(9):653-8.

Cleland JG, Zhang J, Pellicori P, Dicken B, Dierckx R, Shoaib A, et al. Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiol. 2016;1(5):539-47.

Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the Duke Databank. J Am Coll Cardiol. 2007;50(1):40-7.

Danese E, Lippi G, Montagnana M. Red blood cell distribution width and cardiovascular diseases. J Thorac Dis. 2015;7(10):E402-11.

Turcato G, Cervellin G, Salvagno GL, Zaccaria E, Bartucci G, David M, et al. The role of red blood cell distribution width for predicting 1-year mortality in patients admitted to the emergency department with severe dyspnoea. J Med Biochem. 2016;35:1-7.

Shah N, Pahuja M, Pant S, Handa A, Agarwal V, Patel N, et al. Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III. Int J Cardiol. 2017;232:105-10.

WHO. The top 10 causes of death, 2017. Available at: http:// www.who.int/ mediacentre/ factsheets/ fs310/en/. Accessed 29 January 2017.

WHO. Global atlas on cardiovascular disease prevention and control, 2011. Available at: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/. Accessed 29 January 2017.

Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and immediate risk of cardiovascular events: a systematic review and dose-response meta-analysis. Circulation. 2016;133(10):979-87.

Sotiropoulos K, Yerly P, Monney P, Garnier A, Regamey J, Hugli O, et al. Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction. ESC Heart Fail. 2016;3(3):198-204.

Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163-8.

Hong SJ, Youn JC, Oh J, Hong N, Lee HS, Park S, et al. Red cell distribution width as an independent predictor of exercise intolerance and ventilatory inefficiency in patients with chronic heart failure. Yonsei Med J. 2014;55(3):635-43.

Sotiropoulos K, Yerly P, Monney P, Garnier A, Regamey J, Hugli O, et al. Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction. ESC Heart Failure. 2016;3:198-204.

Felker GM, Adams KF Jr, Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004;44(5):959-66.

Spinarová L, Toman J, Pospísilová J, Souĉek M, Kára T, Stejfa M. Humoral response in patients with chronic heart failure. Int J Cardiol. 1998;65(3):227-32.

Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients. Scand J Chin Lab Invest. 2016;68(8):745-8.

Chiari MM, Bagnoli R, De Luca PD, Monti M, Rampoldi E, Cunietti E. Influence of acute inflammation on iron and nutritional status indexes in older inpatients. J Am Geriatr Soc. 1995;43:767-71.

Rohm I, Kretzschmar D, Pistulli R, Franz M, Schulze PC, Stumpf C, et al. Impact of ivabradine on inflammatory markers in chronic heart failure. J Immunol Res. 2016;2016:6949320.

Malik J, Kim AR, Tyre KA, Cherukuri AR, Palis J. Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts. Haematologica. 2013;98(11):1778-87.

Allen LA, Felker GM, Pocock S, McMurray JJ, Pfeffer MA, Swedberg K, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170-7.

Batin P, McEntegart D, Fullwood L, Cowley AJ. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J. 1995;16(11):1613-8.